Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 544 participants.

Also called NCT04790370

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 544 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04790370
Other papers using this trial's data
  • Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism The New England journal of medicine, 2026-05-28 DOI, PubMed 41910345

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Austria, France, Germany, Ireland, Netherlands, Poland, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04790370. Randomized; single masking; primary purpose treatment. Start 2021-08-02 (actual); primary completion 2025-07-31 (actual). Results posted on 2026-11-16.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
Acronym
HI-PEITHO
Intervention (Drug)
Anticoagulation with heparin
Intervention (Device)
EkoSonicTM Endovascular System
Lead sponsor
Boston Scientific Corporation (class: industry)
Collaborator
National PERT Consortium, Inc. (class: not stated)
Collaborator
University Medical Center Mainz (class: other)

Record details

Record id
cardio:ct-nct04790370
Content hash
b051cc93898d29e3c7b5da7c44fde7cc8b545493c424d6aee35b73015dcc4fac